Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestMortgage LoansNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - DoubtfulReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Current Deferred Revenue (2023 - 2025)

WORK Medical Technology filings provide 3 years of Current Deferred Revenue readings, the most recent being $402407.0 for Q3 2025.

  • On a quarterly basis, Current Deferred Revenue fell 35.65% to $402407.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $402407.0, a 35.65% decrease, with the full-year FY2025 number at $402407.0, down 35.65% from a year prior.
  • Current Deferred Revenue hit $402407.0 in Q3 2025 for WORK Medical Technology, down from $1.2 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.2 million in Q1 2025 to a low of $402407.0 in Q3 2025.
  • Median Current Deferred Revenue over the past 3 years was $700768.0 (2023), compared with a mean of $742618.2.
  • Biggest five-year swings in Current Deferred Revenue: dropped 19.44% in 2024 and later crashed 35.65% in 2025.
  • WORK Medical Technology's Current Deferred Revenue stood at $776210.0 in 2023, then decreased by 19.44% to $625326.0 in 2024, then crashed by 35.65% to $402407.0 in 2025.
  • The last three reported values for Current Deferred Revenue were $402407.0 (Q3 2025), $1.2 million (Q1 2025), and $625326.0 (Q3 2024) per Business Quant data.